ORASURE TECHNOLOGIES, INC financials

OSUR CIK 0001116463

Source: EDGAR filings · Built 2026-06-02T03:46:14Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -53.28M 22.73M 134.44M -55.36M -57.96M -21.55M
EBITDA -61.78M -17.38M 53.62M -6.85M 1.49M 4.21M
Working Capital 222.11M 299.74M 346.92M 256.13M 231.24M 242.40M
Net Debt -186.08M -253.16M -276.90M -71.43M -104.49M -154.67M
Gross Margin 41.90% 42.72% 42.33% 38.31% 50.33% 59.32%
Operating Margin -62.57% -15.20% 8.06% -5.72% -4.35% -3.01%
Net Margin -59.76% -10.49% 13.23% -4.42% -9.84% -8.69%
Return on Equity (ROE) -20.17% -4.75% 12.46% -4.70% -6.04% -3.74%
Return on Assets (ROA) -17.05% -4.07% 11.11% -3.86% -4.99% -3.28%
Current Ratio 6.58× 9.95× 9.77× 4.71× 4.40× 6.21×
Debt-to-Equity 0.04× 0.04× 0.03× 0.03× 0.03× 0.02×
Effective Tax Rate -2.79% -11.24% 4.63% -9.30% -147.50% -323.44%
Cash Conversion Ratio 0.71× -1.40× 2.64× 2.75× 1.54× -0.39×
Accruals Ratio -0.05× -0.10× -0.18× 0.07× 0.03× -0.05×
SBC % of Revenue 8.82% 6.41% 2.65% 3.00% 3.34% 4.16%
CapEx Coverage -11.51× 5.90× 19.81× -5.79× -1.57× 0.21×
Free Cash Flow Per Share $-0.73 $0.31 $1.81 $-0.76 $-0.81 $-0.32

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 11.39× 48.14×
P/FCF 11.82× 4.54×
FCF Yield 8.46% 22.04%
EV / EBITDA 6.08× 349.26× 143.71×
P/S 1.48× 1.45× 1.49× 0.90× 2.68× 4.42×
P/B 0.50× 0.66× 1.40× 0.96× 1.65× 1.91×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 115.02M 185.83M 405.47M 387.48M 233.67M 171.72M
Cost of Goods and Services Sold 66.82M 106.44M 233.82M 239.04M 116.07M 69.85M
Gross Profit 48.20M 79.39M 171.65M 148.44M 117.60M 101.87M
Research and Development Expense 42.53M 26.05M 33.73M 36.24M 34.17M 31.03M
Operating Expenses 120.17M 107.64M 138.97M 170.59M 127.76M 107.05M
Operating Income (Loss) -71.97M -28.25M 32.68M -22.16M -10.16M -5.18M
Income Tax Expense (Benefit) 1.80M 1.80M 2.60M 1.46M 13.71M 11.40M
Net Income (Loss) Attributable to Parent -68.73M -19.50M 53.66M -17.13M -23.00M -14.92M
Earnings Per Share, Basic $-0.94 $-0.26 $0.73 $-0.24 $-0.32 $0.22
Weighted Average Number of Shares Outstanding, Basic 73.48M 74.43M 73.35M 72.50M 71.98M 67.50M
Earnings Per Share, Diluted $-0.94 $-0.26 $0.72 $-0.24 $-0.32 $0.22
Weighted Average Number of Shares Outstanding, Diluted 73.48M 74.43M 74.39M 72.50M 71.98M 67.50M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 199.28M 267.76M 290.41M 83.98M 116.76M 160.80M
Assets, Current 261.91M 333.22M 386.46M 325.19M 299.31M 288.89M
Assets 403.17M 479.66M 482.85M 444.18M 460.99M 454.47M
Liabilities, Current 39.80M 33.48M 39.54M 69.06M 68.06M 46.49M
Liabilities 62.34M 69.32M 52.17M 79.75M 80.46M 55.90M
Stockholders' Equity Attributable to Parent 340.83M 410.34M 430.67M 364.43M 380.53M 398.57M
Common Stock, Shares, Outstanding 70.39M 74.60M 73.53M 72.73M 72.07M 71.74M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -49.02M 27.37M 141.58M -47.20M -35.38M 5.81M
Payments to Acquire Property, Plant, and Equipment 4.20M 3.80M 5.80M 6.77M 21.89M 26.67M
Net Cash Provided by (Used in) Investing Activities -6.81M -39.03M 66.15M 21.09M -5.50M -14.03M
Payments for Repurchase of Common Stock 15.04M 0 0 2.25M 2.11M 2.09M
Net Cash Provided by (Used in) Financing Activities -16.94M -4.18M -3.02M -3.83M -2.82M 92.48M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (OSUR CIK 0001116463), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

NHI

National Health Investors, Inc.

VTGN

Vistagen Therapeutics, Inc.

DX

DYNEX CAPITAL, INC.